COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic].
[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic]. Prog Urol. 2021 04; 31(5):243-244.
View in:
PubMed
subject areas
Abiraterone Acetate
Adenocarcinoma
Adrenal Cortex Hormones
Androgen Antagonists
Androgens
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Contraindications, Drug
Humans
Immunosuppressive Agents
Male
Meta-Analysis as Topic
Neoplasms, Hormone-Dependent
Oxygen
Pandemics
Practice Guidelines as Topic
Prospective Studies
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Randomized Controlled Trials as Topic
Respiration, Artificial
Risk
authors with profiles
Patrice Cacoub
Morgan Roupret
G Fournier
F Rozet
Guillaume Ploussard
R Mathieu
Pierre Mongiat-Artus